Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Micro-X Ltd. ( (AU:MX1) ).
Micro-X Ltd has announced a significant $3.3 million order from the Malaysian Ministry of Health for its Rover Plus Mobile DR X-ray units, marking its first major order in Southeast Asia. This order, facilitated by the newly appointed Malaysian distributor Integrated Medical System Sdn Bhd, is a key milestone in Micro-X’s expansion strategy in the region. The delivery of these units is set to begin in October 2025, reinforcing the company’s position in the global market for mobile X-ray solutions. This development not only highlights the growing international recognition of Micro-X’s technology but also underscores the company’s strategy of partnering with experienced local distributors to accelerate market adoption.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an ASX listed hi-tech company specializing in the development and commercialization of innovative products for global health and security markets. The company utilizes proprietary cold cathode, carbon nanotube emitter technology to create x-ray products that are smaller, lighter, and more power-efficient. Micro-X’s product portfolio includes mobile digital radiology products for healthcare, military, and veterinary applications, as well as projects for airport security checkpoints and pre-hospital stroke diagnosis.
Average Trading Volume: 359,347
Technical Sentiment Signal: Buy
Current Market Cap: A$54.76M
For detailed information about MX1 stock, go to TipRanks’ Stock Analysis page.